[Chlorbutin, azathioprine, D-penicillamine, and levamisole (Decaris) in the treatment of rheumatoid arthritis patients. I. Comparative analysis of side effects].
D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001379:Azathioprine / Q000009:adverse effects*; D001986:Bronchial Spasm / Q000139:chemically induced; D002699:Chlorambucil / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology; D004415:Dyspepsia / Q000139:chemically induced; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D007978:Levamisole / Q000009:adverse effects*; D009369:Neoplasms / Q000139:chemically induced; D010396:Penicillamine / Q000009:adverse effects*; D013997:Time Factors
D002699:Chlorambucil; D007978:Levamisole; D010396:Penicillamine; D001379:Azathioprine
Khlorbutin, azatioprin, D-penitsillamin i levamizol (Dekaris) v lechenii bol'nykh revmatoidnym artritom. I. Sravnitel'nyĭ analiz pobochnykh iavleniĭ.